The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Birner Hubert since 2011.
The trader's CIK number is 1398598.
At the time of the last reporting, Birner Hubert was the Director of Argos Therapeutics Inc. (stock ticker symbol ARGS).
Also see all insider trading activities at Argos Therapeutics Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2014 | PRTO | 300,000 | $3,000,000 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2011 | HZNP | 156,162 | $1,405,458 | 0 | $0 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2016 | ARGS | 459,242 | $0 | 0 | $0 | 0 | $0 |
2014 | ARGS | 39,873 | $318,984 | 0 | $0 | 0 | $0 |
1. Protara Therapeutics, Inc. (PRTO)
2. Horizon Therapeutics Public Ltd Co (HZNP)
3. Argos Therapeutics Inc (ARGS)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-10-27 | PRTO | Buy | 300,000 | 10.00 | 3,000,000 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2011-08-02 | HZNP | Buy | 156,162 | 9.00 | 1,405,458 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2016-06-29 | ARGS | Buy | 275,545 | .00 | 0 |
2016-03-14 | ARGS | Buy | 183,697 | .00 | 0 |
2014-02-12 | ARGS | Buy | 39,873 | 8.00 | 318,984 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Birner Hubert (Director of Argos Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.